Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...

America wants to reduce its reliance on Chinese supply chains, since it remains in a trade war that is only temporarily on hold. The government frets already about China’s chokehold on active drug ...

What China is accomplishing in R&D “has implications for everyone playing in the R&D or innovation world,” McKinsey’s Fangning Zhang says.

Sam Altman’s longevity startup Retro Bio seeks to raise $5 billion valuation; Trump pollster advises House GOP on healthcare ...

American pharmaceutical firm Inotiv is notifying thousands of people that they're personal information was stolen in an ...

On December 5, 2025, Medicus Pharma Ltd. entered into a warrant inducement agreement to facilitate the exercise of existing warrants, expecting gross proceeds of approximately $5.1 million. The ...

Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Sun Pharma, including: ...

FDA extends Ascendis' TransCon CNP review to Feb. 28, 2026, after new data submission related to post-marketing study ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Cinclus Pharma Holding AB ( ($SE:CINPHA) ) just unveiled an announcement. Cinclus Pharma Holding AB has announced an Extraordinary General Meeting ...

Frankfurt Airport joins Pharma.Aero, the global cross-industry collaboration platform, expanding the organisation’s ...